Victoza vs. Amaryl
See how Victoza and Amaryl compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Victoza is an injectable GLP-1 medicine also approved to lower cardiovascular risk in adults with type 2 diabetes and heart disease, while Amaryl only manages blood sugar.
Amaryl is a low-cost oral generic pill taken once daily, while Victoza requires a daily injection.
Victoza carries a boxed warning for thyroid tumor risk seen in animal studies, while Amaryl's main risk is hypoglycemia, especially with skipped meals.
Victoza vs. Amaryl Drug Summary
Victoza
Victoza (liraglutide) is a GLP-1 receptor agonist used to improve blood sugar control in adults and children with type 2 diabetes. It's also approved to reduce the risk of major cardiovascular events in adults with type 2 diabetes and known heart disease. It's given as a once-daily injection under the skin.
Amaryl
Amaryl (glimepiride) is a sulfonylurea that helps the pancreas release more insulin to lower blood sugar in adults with type 2 diabetes. It's taken as a once-daily oral tablet and can be combined with insulin if needed. It has been used clinically since 1995.
Victoza vs. Amaryl Side Effects
Victoza
Amaryl
Victoza vs. Amaryl Dosage
Victoza
Amaryl
| STAGE | DOSE | WHEN |
| Starting dose | 0.6 mg once daily | Week 1 |
| Maximum dose | 1.8 mg once daily | Week 3 onward |
| Dose changes | 2 increases | Every week |
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg or 2 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Victoza
| STAGE | DOSE | WHEN |
| Starting dose | 0.6 mg once daily | Week 1 |
| Maximum dose | 1.8 mg once daily | Week 3 onward |
| Dose changes | 2 increases | Every week |
Amaryl
| STAGE | DOSE | WHEN |
| Starting dose | 1 mg or 2 mg once daily | At the start |
| Maximum dose | 8 mg once daily | If needed |
| Dose changes | 2 increases | As tolerated |
Victoza vs. Amaryl Indications
Victoza
Victoza is FDA-approved as an add-on to diet and exercise for adults and children 10 and older with type 2 diabetes. It's also approved to reduce major cardiovascular events in adults with type 2 diabetes and established heart disease. It's not approved for type 1 diabetes.
Improves blood sugar control alongside diet and exercise
FDA-approved for cardiovascular risk reduction
Approved for children 10 years and older
Not approved for type 1 diabetes
Amaryl
Amaryl is FDA-approved as an add-on to diet and exercise to improve blood sugar control in adults with type 2 diabetes. It can also be combined with insulin when either medicine alone isn't enough. It's not approved for type 1 diabetes or diabetic ketoacidosis.
Improves blood sugar control alongside diet and exercise
Approved for combination use with insulin
Only approved for adults, not children
Not approved for type 1 diabetes or DKA
Victoza vs. Amaryl Pros and Cons
Victoza
Victoza's cardiovascular benefit and GLP-1 mechanism make it a strong option for patients with heart disease risk, but it requires daily injections and costs far more than older oral drugs. Insurance coverage varies and prior authorization is often required.
Pros
FDA-approved to reduce cardiovascular events
Low risk of hypoglycemia when used alone
Often reduces appetite and supports weight loss
Approved for pediatric use starting at age 10
Cons
Requires daily self-injection
Boxed warning for thyroid C-cell tumor risk
Risk of acute pancreatitis
Typically $935 to $1,470 per month without insurance
Amaryl
Amaryl offers a simple once-daily pill and one of the lowest costs among diabetes medicines, making it accessible for many patients. Its main tradeoff is a real risk of hypoglycemia and no proven cardiovascular benefit.
Pros
Taken as a once-daily oral tablet
Widely available as an inexpensive generic
Can be combined with insulin if needed
Typically $15 to $110 per month without insurance
Cons
Risk of hypoglycemia, especially with missed meals
No cardiovascular risk reduction benefit
Possible cardiovascular mortality signal from older sulfonylurea data
Not approved for pediatric patients
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.